Home > USA > Investors > News Releases
 
 
 
HomeAbout UsProducts & TechnologyCliniciansPatients & FamiliesMedia CentreInvestor Centre
 
 
Investor Centre
 
Welcome'width='178
Corporate Profile
Investor Fact Sheet
Share Price Information
ASX Announcements
SEC Filings
News Releases
Annual Reports
Corporate Presentations
Events Calendar
Corporate Governance
Shareholder Services
Analyst Coverage
Investor FAQs
Email Alerts
Contact Investor Relations
 
 
 
 
 
  News Releases
 
 

Email Alerts Receive Email Alerts | RSS RSS Feeds
Keyword Search
 
2010 | 2009
DateTitle 
09/03/10HeartWare Receives Second Patient Allotment Under Continued Access Protocol for Pivotal U.S. Bridge-To-Transplant Clinical TrialPrinter Friendly Version
08/05/10HeartWare International Reports Second Quarter 2010 Revenues of $9.8 Million; Compared to $3.0 Million in Second Quarter 2009Printer Friendly Version
08/04/10HeartWare to Present at The Canaccord Genuity 30th Annual Growth ConferencePrinter Friendly Version
07/29/10HeartWare to Present at the Wedbush Securities 2010 Life Sciences Best Ideas ConferencePrinter Friendly Version
07/27/10HeartWare to Report Financial Results for Second Quarter of 2010Printer Friendly Version
06/24/10HeartWare Announces Board SuccessionPrinter Friendly Version
06/17/10HeartWare to Present at the Wells Fargo Securities 2010 Healthcare ConferencePrinter Friendly Version
06/14/10HeartWare Receives Conditional FDA Approval to Commence Pivotal Destination Therapy Clinical Trial in the U.S.Printer Friendly Version
05/06/10HeartWare to Present at Bank of America Merrill Lynch Health Care Conference in New YorkPrinter Friendly Version
05/03/10HeartWare International Reports First Quarter 2010 Revenues of $10.7 Million; Compared With $1.5 Million In First Quarter 2009Printer Friendly Version
04/26/10HeartWare Initiates Repairs and Partial Recall of ControllersPrinter Friendly Version
04/23/10HeartWare Data From First 100 Patients in International Clinical and Commercial Experience Shows 90% Survival at 180 DaysPrinter Friendly Version
04/12/10HeartWare to Report Financial Results for First Quarter of 2010Printer Friendly Version
04/07/10HeartWare Receives FDA Approval of Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical TrialPrinter Friendly Version
03/11/10HeartWare to Present at the Barclays Capital 2010 Global Healthcare ConferencePrinter Friendly Version
03/04/10HeartWare to Present at the Roth Capital Partners OC Growth Stock ConferencePrinter Friendly Version
02/22/10HeartWare International Reports Fourth Quarter Revenues of $12.2 Million; Full Year 2009 Revenues of $24.2 MillionPrinter Friendly Version
02/22/10HeartWare Announces Early Conclusion of Enrollment for U.S. Bridge-to-Transplant Clinical TrialPrinter Friendly Version
02/08/10HeartWare to Report 2009 Fourth Quarter and Year-End Financial ResultsPrinter Friendly Version
02/02/10HeartWare International, Inc. Announces Completion of Public Offering of Common StockPrinter Friendly Version
01/27/10HeartWare International, Inc. Announces Pricing of Public Offering of Common StockPrinter Friendly Version
01/26/10HeartWare International, Inc. Announces Commencement of Public Offering of Common StockPrinter Friendly Version
01/06/10HeartWare to Present at J.P. Morgan Healthcare Conference in San FranciscoPrinter Friendly Version
11/25/09HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York CityPrinter Friendly Version
11/06/09HeartWare to Present at Upcoming Investment Conferences in NovemberPrinter Friendly Version
11/04/09HeartWare International Reports Third Quarter Revenues of $7.5 MillionPrinter Friendly Version
10/29/09Advance Notice of Q3 Earnings CallPrinter Friendly Version
10/05/09U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical TrialPrinter Friendly Version
09/01/09HeartWare International, Inc. Temporary Suspension of TradingPrinter Friendly Version
08/20/09HeartWare International Surpasses 50 Implants in the USPrinter Friendly Version
08/17/09HeartWare International, Inc. Closes US$60 Million FinancingPrinter Friendly Version
08/11/09HeartWare to Present at Canaccord Adams 29th Annual Global Growth ConferencePrinter Friendly Version
08/10/09HeartWare International, Inc. Announces US$55 Million FinancingPrinter Friendly Version
07/31/09Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed TransactionPrinter Friendly Version
07/29/09U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare InternationalPrinter Friendly Version
05/12/09HeartWare to Present at Eighth Annual JMP Securities Research ConferencePrinter Friendly Version
04/24/09HeartWare International Clinical Trial Shows 90% Survival at 180 DaysPrinter Friendly Version

 
 
Copyright © HeartWare International, Inc.